122 related articles for article (PubMed ID: 38106191)
1. Packaging of supplemented urokinase into naked alpha-granules of
Poncz M; Zaitsev SV; Ahn H; Kowalska MA; Bdeir K; Camire RM; Cines DB; Stepanova V
bioRxiv; 2023 Dec; ():. PubMed ID: 38106191
[TBL] [Abstract][Full Text] [Related]
2. Packaging of supplemented urokinase into alpha-granules of in vitro-grown megakaryocytes for targeted nascent clot lysis.
Poncz M; Zaitsev S; Ahn H; Kowalska MA; Bdeir K; Dergilev KV; Ivanciu L; Camire RM; Cines DB; Stepanova V
Blood Adv; 2024 May; ():. PubMed ID: 38805575
[TBL] [Abstract][Full Text] [Related]
3. Packaging functionally important plasma proteins into the α-granules of human-induced pluripotent stem cell-derived megakaryocytes.
Zhang N; Newman PJ
J Tissue Eng Regen Med; 2019 Feb; 13(2):244-252. PubMed ID: 30556311
[TBL] [Abstract][Full Text] [Related]
4. RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects.
Lee K; Ahn HS; Estevez B; Poncz M
Blood; 2023 Jan; 141(3):260-270. PubMed ID: 36219879
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.
Veljkovic DK; Rivard GE; Diamandis M; Blavignac J; Cramer-Bordé EM; Hayward CP
Blood; 2009 Feb; 113(7):1535-42. PubMed ID: 19029443
[TBL] [Abstract][Full Text] [Related]
6. A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation.
Fuentes RE; Zaitsev S; Ahn HS; Hayes V; Kowalska MA; Lambert MP; Wang Y; Siegel DL; Bougie DW; Aster RH; Myers DD; Stepanova V; Cines DB; Muzykantov VR; Poncz M
J Clin Invest; 2016 Feb; 126(2):483-94. PubMed ID: 26690701
[TBL] [Abstract][Full Text] [Related]
7. Gray platelet syndrome: immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes.
Cramer EM; Vainchenker W; Vinci G; Guichard J; Breton-Gorius J
Blood; 1985 Dec; 66(6):1309-16. PubMed ID: 3877532
[TBL] [Abstract][Full Text] [Related]
8. Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII.
Wilcox DA; Shi Q; Nurden P; Haberichter SL; Rosenberg JB; Johnson BD; Nurden AT; White GC; Montgomery RR
J Thromb Haemost; 2003 Dec; 1(12):2477-89. PubMed ID: 14675082
[TBL] [Abstract][Full Text] [Related]
9. Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake.
Sim X; Jarocha D; Hayes V; Hanby HA; Marks MS; Camire RM; French DL; Poncz M; Gadue P
Blood; 2017 Jul; 130(2):192-204. PubMed ID: 28455282
[TBL] [Abstract][Full Text] [Related]
10. Platelet α-granule cargo packaging and release are affected by the luminal proteoglycan, serglycin.
Chanzu H; Lykins J; Wigna-Kumar S; Joshi S; Pokrovskaya I; Storrie B; Pejler G; Wood JP; Whiteheart SW
J Thromb Haemost; 2021 Apr; 19(4):1082-1095. PubMed ID: 33448622
[TBL] [Abstract][Full Text] [Related]
11. Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets.
Schmitt A; Guichard J; Massé JM; Debili N; Cramer EM
Exp Hematol; 2001 Nov; 29(11):1295-302. PubMed ID: 11698125
[TBL] [Abstract][Full Text] [Related]
12. Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation.
Guerrero JA; Kyei M; Russell S; Liu J; Gartner TK; Storrie B; Ware J
Blood; 2009 Dec; 114(27):5541-6. PubMed ID: 19808696
[TBL] [Abstract][Full Text] [Related]
13. NBEAL2 (Neurobeachin-Like 2) Is Required for Retention of Cargo Proteins by α-Granules During Their Production by Megakaryocytes.
Lo RW; Li L; Leung R; Pluthero FG; Kahr WHA
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2435-2447. PubMed ID: 30354215
[TBL] [Abstract][Full Text] [Related]
14. Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.
Ayombil F; Abdalla S; Tracy PB; Bouchard BA
J Thromb Haemost; 2013 Aug; 11(8):1532-9. PubMed ID: 23710903
[TBL] [Abstract][Full Text] [Related]
15. Intramedullary megakaryocytes internalize released platelet factor 4 and store it in alpha granules.
Lambert MP; Meng R; Xiao L; Harper DC; Marks MS; Kowalska MA; Poncz M
J Thromb Haemost; 2015 Oct; 13(10):1888-99. PubMed ID: 26256688
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis.
Iakhiaev AV; Nalian A; Koenig K; Idell S
Thromb Res; 2007; 120(5):715-25. PubMed ID: 17275887
[TBL] [Abstract][Full Text] [Related]
17. The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes.
Hayward CP; Liang M; Tasneem S; Soomro A; Waye JS; Paterson AD; Rivard GE; Wilson MD
PLoS One; 2017; 12(3):e0173991. PubMed ID: 28301587
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
19. Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.
Wang X; Palasubramaniam J; Gkanatsas Y; Hohmann JD; Westein E; Kanojia R; Alt K; Huang D; Jia F; Ahrens I; Medcalf RL; Peter K; Hagemeyer CE
Circ Res; 2014 Mar; 114(7):1083-93. PubMed ID: 24508759
[TBL] [Abstract][Full Text] [Related]
20. Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes.
Cramer EM; Debili N; Martin JF; Gladwin AM; Breton-Gorius J; Harrison P; Savidge GF; Vainchenker W
Blood; 1989 Apr; 73(5):1123-9. PubMed ID: 2649167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
